Anthera Pharmaceuticals OverviewAnthera Pharmaceuticals Research & Development
Research & Development expenses for ANTH.
Quarterly R&D Expenses
$7.47M
↓ 4.27% YoY
As of Mar 31, 2018
Annual R&D Expenses (TTM)
$28.26M
↓ 36.39% YoY
Trailing 12 months ending Mar 31, 2018